HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xin Xie Selected Research

caffeic acid 3,4-dihydroxyphenethyl ester

1/2021Antileukemic effect of caffeic acid 3,4-dihydroxyphenetyl ester. Evidences for its mechanisms of action.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xin Xie Research Topics

Disease

72Neoplasms (Cancer)
10/2022 - 11/2004
12Inflammation (Inflammations)
08/2022 - 01/2013
10Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
06/2022 - 09/2011
10Infections
06/2021 - 09/2013
9Autoimmune Diseases (Autoimmune Disease)
10/2022 - 04/2008
9Breast Neoplasms (Breast Cancer)
01/2022 - 09/2013
9Multiple Sclerosis
06/2017 - 09/2011
8Hypoxia (Hypoxemia)
10/2022 - 05/2014
8Neoplasm Metastasis (Metastasis)
05/2022 - 06/2014
8Melanoma (Melanoma, Malignant)
01/2022 - 09/2005
8Carcinogenesis
12/2021 - 01/2013
7Cardiomegaly (Heart Hypertrophy)
01/2020 - 02/2013
6Fibrosis (Cirrhosis)
01/2022 - 07/2015
6Wounds and Injuries (Trauma)
10/2021 - 11/2003
6Stomach Neoplasms (Stomach Cancer)
07/2021 - 01/2017
6Pancreatic Neoplasms (Pancreatic Cancer)
07/2021 - 08/2014
5Human Influenza (Influenza)
11/2021 - 02/2015
5Huntington Disease (Huntington's Disease)
01/2021 - 11/2007
5Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2013
5Carcinoma (Carcinomatosis)
01/2021 - 01/2005
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 11/2007
5Alzheimer Disease (Alzheimer's Disease)
11/2019 - 11/2007
5Hypertrophy
01/2019 - 02/2013
4Demyelinating Diseases (Demyelinating Disease)
10/2022 - 01/2018
4Urinary Bladder Neoplasms (Bladder Cancer)
12/2021 - 01/2017
4Necrosis
12/2021 - 11/2003
4Heart Failure
10/2021 - 01/2018
4Hepatocellular Carcinoma (Hepatoma)
01/2021 - 06/2014
4Obesity
01/2021 - 05/2019
4Colonic Neoplasms (Colon Cancer)
01/2021 - 08/2013
4Insulin Resistance
12/2020 - 06/2015
4Pain (Aches)
10/2020 - 03/2015
4Type 2 Diabetes Mellitus (MODY)
01/2020 - 01/2007
3Ulcerative Colitis
10/2022 - 12/2020
3Colitis
10/2022 - 12/2018
3Starvation
01/2021 - 12/2004
3Adenocarcinoma
01/2021 - 01/2005
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 01/2018
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 03/2003
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2019
3Cardiovascular Diseases (Cardiovascular Disease)
05/2019 - 01/2010
3Hypoglycemia (Reactive Hypoglycemia)
01/2019 - 01/2007
3Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2018 - 01/2016
3Atherosclerosis
01/2018 - 02/2010
3Pheochromocytoma
11/2017 - 12/2011
2Atrial Fibrillation
11/2022 - 01/2022
2Vitiligo
10/2022 - 04/2013
2Substance-Related Disorders (Drug Abuse)
04/2022 - 04/2021
2Adenocarcinoma of Lung
01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

38Pharmaceutical PreparationsIBA
10/2022 - 01/2007
24Proteins (Proteins, Gene)FDA Link
10/2022 - 09/2005
12Biomarkers (Surrogate Marker)IBA
10/2022 - 09/2015
9Biological ProductsIBA
01/2021 - 01/2005
7LipopolysaccharidesIBA
10/2022 - 01/2014
7LigandsIBA
10/2022 - 09/2002
7Messenger RNA (mRNA)IBA
10/2022 - 10/2014
7Therapeutic UsesIBA
01/2022 - 08/2013
7CytokinesIBA
06/2021 - 11/2003
7Long Noncoding RNAIBA
01/2021 - 01/2018
7Glucose (Dextrose)FDA LinkGeneric
01/2021 - 12/2004
7G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2021 - 07/2012
6AntigensIBA
01/2022 - 01/2005
6LipidsIBA
12/2021 - 06/2017
5Interleukin-6 (Interleukin 6)IBA
12/2020 - 11/2003
5Glycoproteins (Glycoprotein)IBA
01/2018 - 01/2012
4CuprizoneIBA
10/2022 - 01/2018
4VaccinesIBA
01/2022 - 09/2015
4AntioxidantsIBA
07/2021 - 01/2012
4MicroRNAs (MicroRNA)IBA
01/2020 - 01/2018
4Indicators and Reagents (Reagents)IBA
12/2019 - 01/2014
4AntibodiesIBA
11/2019 - 02/2010
4Illicit Drugs (Recreational Drugs)IBA
01/2019 - 06/2017
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2018 - 09/2007
4Phosphotransferases (Kinase)IBA
01/2018 - 09/2007
3Toll-Like Receptors (Toll-Like Receptor)IBA
10/2022 - 11/2003
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 01/2013
3UbiquitinIBA
12/2021 - 04/2017
3oxidized low density lipoproteinIBA
12/2021 - 02/2010
3Oxygen (Dioxygen)IBA
03/2021 - 02/2010
3Transcription Factors (Transcription Factor)IBA
01/2021 - 04/2011
3Cadherins (E-Cadherin)IBA
01/2021 - 01/2019
3Hormones (Hormone)IBA
01/2021 - 01/2007
3CateninsIBA
01/2021 - 08/2013
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 06/2020
3Antiviral Agents (Antivirals)IBA
11/2020 - 01/2012
3RNA (Ribonucleic Acid)IBA
05/2020 - 01/2019
3ChemokinesIBA
01/2020 - 02/2013
3Interleukin-17 (Interleukin 17)IBA
01/2020 - 09/2011
3EpitopesIBA
06/2019 - 02/2015
3Small Interfering RNA (siRNA)IBA
01/2018 - 01/2005
3IntegrinsIBA
01/2017 - 09/2007
3Cantharidin (Cantharides)IBA
02/2015 - 09/2013
2Melanins (Melanin)IBA
10/2022 - 01/2020
2InflammasomesIBA
08/2022 - 01/2019
2indoleIBA
05/2022 - 01/2016
2Interleukin-12 (IL 12)IBA
01/2022 - 11/2003

Therapy/Procedure

30Therapeutics
01/2022 - 01/2007
11Immunotherapy
01/2022 - 03/2016
10Drug Therapy (Chemotherapy)
01/2022 - 04/2014
6Radiotherapy
12/2021 - 01/2018